In this work, we find that although Slit2 levels are diminished in SCLC tumors, the SCLC‐Y subtype, which has the best prognosis for SCLC patients [49], has the highest expression of Slit2, compared with more aggressive SCLC. The gene discussed is SLIT2; the disease is small cell lung carcinoma.